Cedar Mountain Advisors
COLL icon

Cedar Mountain Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Cedar Mountain Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$611 Buy
+28
New +$817 ﹤0.01% 990
2026
Q2 		– Sell
-6
Closed -$198 – 1185
2026
Q1 		$198 Buy
+6
New +$254 ﹤0.01% 1097

Other funds holding COLL

Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Kendall Capital Management
Kendall Capital Management Rockville, Maryland $605M AUM 38.16% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Cedar Mountain Advisors's COLL Position: Q3 2026 in Review

Cedar Mountain Advisors opened a new position in Collegium Pharmaceutical (COLL) in Q3 2026: 28 shares worth $611. The stake represents ﹤0.01% of the portfolio and ranks #990 among its holdings. This is a return to the name: Cedar Mountain Advisors previously reported a position in COLL as recently as Q1 2026.

Cedar Mountain Advisors first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 28 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Cedar Mountain Advisors held 28 shares of Collegium Pharmaceutical worth $611 as of Q3 2026.
  • Collegium Pharmaceutical was a new Cedar Mountain Advisors position in Q3 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #990 holding.
  • Cedar Mountain Advisors first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 28 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.